DNA methylation of DKK3 modulates docetaxel chemoresistance in human nonsmall cell lung cancer cell

Cancer Biotherapy and Radiopharmaceuticals

Volumn 30, Issue 2, 2015, Pages 100-106

  Tao, Leilei ^a   Huang, Guichun ^a   Chen, Yitian ^a   Chen, Longbang ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

chemoresistance; DKK3; DNA methylation; docetaxel; NSCLC

Indexed keywords

DICKKOPF PROTEIN 3; DOCETAXEL; GLYCOPROTEIN; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; UNCLASSIFIED DRUG; DKK3 PROTEIN, HUMAN; SIGNAL PEPTIDE; TAXOID;

APOPTOSIS; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CHEMOSENSITIVITY; COLONY FORMATION; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; GENE OVEREXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IC50; IN VITRO STUDY; NON SMALL CELL LUNG CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; TRANSIENT TRANSFECTION; UPREGULATION; CARCINOMA, NON-SMALL-CELL LUNG; DOWN REGULATION; DRUG EFFECTS; DRUG RESISTANCE; GENETIC EPIGENESIS; GENETICS; LUNG NEOPLASMS; TUMOR CELL LINE;

APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL PROLIFERATION; DNA METHYLATION; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; EPIGENESIS, GENETIC; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; P-GLYCOPROTEIN; TAXOIDS;

EID: 84924561380     PISSN: 10849785     EISSN: 15578852     Source Type: Journal    
DOI: 10.1089/cbr.2014.1797     Document Type: Article

References (24)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63: 11.
2. Joshi M, Liu X, Belani CP. Taxanes, past, present, and future impact on non-small cell lung cancer. Anticancer Drugs 2014; 25: 571.
3. Mistry SJ, OhWK. New paradigms in microtubule-mediated endocrine signaling in prostate cancer. Mol Cancer Ther 2013; 12: 555.
4. Marzo I, Naval J. Antimitotic drugs in cancer chemotherapy: Promises and pitfalls. Biochem Pharmacol 2013; 86: 703.
5. Kuczynski EA, Sargent DJ, Grothey A, et al. Drug rechallenge and treatment beyond progression-implications for drug resistance. Nat Rev Clin Oncol 2013; 10: 571.
6. Feng B, Wang R, Song HZ, et al. MicroRNA-200b reverses chemoresistance of docetaxel-resistant human lung adenocarcinoma cells by targeting E2F3. Cancer 2012; 118: 3365.
7. Feng B, Wang R, Chen LB. MiR-100 resensitizes docetaxelresistant human lung adenocarcinoma cells (SPC-A1) to docetaxel by targeting Plk1. Cancer Lett 2012; 317: 184.
8. Staub J, Chien J, Pan Y, et al. Epigenetic silencing of HSulf-1 in ovarian cancer: Implications in chemoresistance. Oncogene 2007; 26: 4969.
9. Jung IL, Kang HJ, Kim KC, et al. Knockdown of the Dickkopf 3 gene induces apoptosis in a lung adenocarcinoma. Int J Mol Med 2010; 26: 33.
10. Yue W, Sun Q, Dacic S, et al. Downregulation of Dkk3 activates b-catenin/TCF-4 signaling in lung cancer. Carcinogenesis 2008; 29: 84.
11. Jiang T, Huang L, Wang S, et al. Clinical significance of serum Dkk-3 in patients with gynecological cancer. J Obstet Gynaecol Res 2010; 36: 769.
12. Guo CC, Zhang XL, Yang B, et al. Decreased expression of Dkk1 and Dkk3 in human clear cell renal cell carcinoma. Mol Med Rep 2014; 9: 2367.
13. Zenzmaier C, Heitz M, Klocker H, et al. Elevated levels of Dickkopf-related protein 3 in seminal plasma of prostate cancer patients. J Transl Med 2011; 9: 193.
14. Rui W, Bing F, Hai-Zhu S, et al. Identification of micro- RNA profiles in docetaxel-resistant human non-small cell lung carcinoma cells (SPC-A1). J Cell Mol Med 2010; 14: 206.
15. Cui S-Y, Huang J-Y, Chen Y-T, et al. Let-7c governs the acquisition of chemo-or radioresistance and epithelial- to-mesenchymal transition phenotypes in docetaxelresistant lung adenocarcinoma. Mol Cancer Res 2013; 11: 699.
16. Dumontet C, Jordan MA. Microtubule-binding agents: A dynamic field of cancer therapeutics. Nat Rev Drug Discov 2010; 9: 790.
17. Leandro-García LJ, Leskelä S, Landa I, et al. Tumoral and tissue-specific expression of the major human b-tubulin isotypes. Cytoskeleton 2010; 67: 214.
18. Zhu Y, Liu C, Nadiminty N, et al. Inhibition of ABCB1 expression overcomes acquired docetaxel resistance in prostate cancer. Mol cancer Ther 2013; 12: 1829.
19. Choi HJ, Park H, Lee HW, et al. The Wnt pathway and the roles for its antagonists, DKKS, in angiogenesis. IUBMB Life 2012; 64: 724.
20. Sharma S, Kelly TK, Jones PA. Epigenetics in cancer. Carcinogenesis 2010; 31: 27.
21. Xiang T, Li L, Yin X, et al. Epigenetic silencing of the WNT antagonist Dickkopf 3 disrupts normal Wnt/b-catenin signalling and apoptosis regulation in breast cancer cells. J Cell Mol Med 2013; 17: 1236.
22. Ueno K, Hirata H, Majid S, et al. Wnt antagonist DICKKOPF- 3 (Dkk-3) induces apoptosis in human renal cell carcinoma. Mol Carcinog 2011; 50: 449.
23. González-Vacarezza N, Dorado P, Peñas-Lledó EM, et al. MDR-1 genotypes and quetiapine pharmacokinetics in healthy volunteers. Drug Metab Drug Interact 2013; 28: 163.
24. Binkhathlan Z, Lavasanifar A. P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: Current status and future perspectives. Curr Cancer Drug Targets 2013; 13: 326.